Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Neurogastroenterology and Motility
|
July 26, 2024
The COVID-19 pandemic as a modifier of DGBI symptom severity: A systematic review and meta-analysis
Dmitrii Kulin, Ayesha Shah, Thomas Fairlie, et al.
Hepatology Communications
|
January 11, 2024
Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysis
Ayesha Shah, Michael P Jones, Gavin Callaghan, et al.
Journal of Clinical Gastroenterology
|
April 18, 2020
Induction of Meal-related Symptoms as a Novel Mechanism of Action of the Duodenal-Jejunal Bypass Sleeve
Jessica J McMaster, Graeme G Rich, Erin R Shanahan, et al.
Hepatology (Baltimore, Md.)
|
January 27, 2023
Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis
Ahmad H Ali, Cynthia W Buness, Ryan Fischer, et al.
Digestive Diseases and Sciences
|
April 1, 2022
Evaluation of a Multidisciplinary Integrated Treatment Approach Versus Standard Model of Care for Functional Gastrointestinal Disorders (FGIDS): A Matched Cohort Study
Nicola A Bray, Natasha A Koloski, Michael P Jones, et al.
Diabetes Care
|
January 30, 2023
Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide
Robert E J Ryder, Katharina Laubner, Marek Benes, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Neurogastroenterology and Motility
|
July 26, 2024
The COVID-19 pandemic as a modifier of DGBI symptom severity: A systematic review and meta-analysis
Dmitrii Kulin, Ayesha Shah, Thomas Fairlie, et al.
Hepatology Communications
|
January 11, 2024
Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysis
Ayesha Shah, Michael P Jones, Gavin Callaghan, et al.
Journal of Clinical Gastroenterology
|
April 18, 2020
Induction of Meal-related Symptoms as a Novel Mechanism of Action of the Duodenal-Jejunal Bypass Sleeve
Jessica J McMaster, Graeme G Rich, Erin R Shanahan, et al.
Hepatology (Baltimore, Md.)
|
January 27, 2023
Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis
Ahmad H Ali, Cynthia W Buness, Ryan Fischer, et al.
Digestive Diseases and Sciences
|
April 1, 2022
Evaluation of a Multidisciplinary Integrated Treatment Approach Versus Standard Model of Care for Functional Gastrointestinal Disorders (FGIDS): A Matched Cohort Study
Nicola A Bray, Natasha A Koloski, Michael P Jones, et al.
Diabetes Care
|
January 30, 2023
Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide
Robert E J Ryder, Katharina Laubner, Marek Benes, et al.
Page
of 6